Researchers in Israel found that patients who take bisphosphonates - including Fosomax, Boniva, Actonel and Reclast - cut their cancer risk by almost 60 percent. Previous studies linked the drugs to a reduced risk of developing /*breast cancer*/.
While patients taking the drugs had a reduced cancer rate, researchers say more tests are needed to prove the medication is preventing some cancers.
